Compare, Analyse Piramal Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs MYLAN (US) - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   MYLAN
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
MYLAN
Dec-18
PIRAMAL ENTERPRISES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,3033,521-   
Low Rs1,7971,938-   
Sales per share (Unadj.) Rs716.51,620.2-  
Earnings per share (Unadj.) Rs79.744.0-  
Cash flow per share (Unadj.) Rs107.9347.3-  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.51,752.7-  
Shares outstanding (eoy) m184.45514.50-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.61.7 211.2%   
Avg P/E ratio x32.062.0 51.6%  
P/CF ratio (eoy) x23.67.9 300.7%  
Price / Book Value ratio x1.71.6 110.8%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2921,404,324 33.5%   
No. of employees `0007.835.0 22.3%   
Total wages/salary Rs m22,5040-   
Avg. sales/employee Rs Th16,899.423,816.2 71.0%   
Avg. wages/employee Rs Th2,877.70-   
Avg. net profit/employee Rs Th1,879.9646.7 290.7%   
INCOME DATA
Net Sales Rs m132,153833,568 15.9%  
Other income Rs m3,1280-   
Total revenues Rs m135,281833,568 16.2%   
Gross profit Rs m66,290215,697 30.7%  
Depreciation Rs m5,202156,077 3.3%   
Interest Rs m44,09740,092 110.0%   
Profit before tax Rs m20,11919,528 103.0%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611-3,107 -277.2%   
Profit after tax Rs m14,70122,635 64.9%  
Gross profit margin %50.225.9 193.8%  
Effective tax rate %42.8-15.9 -269.0%   
Net profit margin %11.12.7 409.7%  
BALANCE SHEET DATA
Current assets Rs m122,742465,464 26.4%   
Current liabilities Rs m310,810339,374 91.6%   
Net working cap to sales %-142.315.1 -940.8%  
Current ratio x0.41.4 28.8%  
Inventory Days Days2384 27.6%  
Debtors Days Days3993 41.6%  
Net fixed assets Rs m116,904161,698 72.3%   
Share capital Rs m369444 83.1%   
"Free" reserves Rs m272,1610-   
Net worth Rs m272,530901,768 30.2%   
Long term debt Rs m270,196973,297 27.8%   
Total assets Rs m856,2612,418,893 35.4%  
Interest coverage x1.51.5 97.9%   
Debt to equity ratio x1.01.1 91.9%  
Sales to assets ratio x0.20.3 44.8%   
Return on assets %6.92.6 264.8%  
Return on equity %5.42.5 214.9%  
Return on capital %12.43.2 390.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,3120-   
CASH FLOW
From Operations Rs m-115,975173,216 -67.0%  
From Investments Rs m-8,265-89,533 9.2%  
From Financial Activity Rs m107,525-80,694 -133.3%  
Net Cashflow Rs m-16,6501,435 -1,160.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.97 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  WOCKHARDT  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Sensex Corrects Over 600 Points; Private Bank & IT Stocks Under Pressure(02:30 pm)

Share markets in India have extended losses and are presently trading deep in the red, dragged down by financials and IT stocks.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

This Diwali Consider Richa's #1 Stock Pick for 2021 (Profit Hunter)

Nov 13, 2020

Why I admire the approach that Richa uses to zero in on stocks with huge upside potential.

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now... Views On News (Views On News)

Nov 12, 2020

Rahul Shah discusses why he preferred a little known stock over Nestle Ltd and how he was proven right.

How to Short Sell the Right Way (Fast Profits Daily)

Nov 13, 2020

In this video, I'll show you how to short sell effectively.

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

US Elections: Won a Battle, Now the War (The Honest Truth)

Nov 13, 2020

Ajit Dayal on the urgent need to fix the disparity between the rich and the poor in the US.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PIRAMAL ENTERPRISES SHARE PRICE


Nov 25, 2020 03:36 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - ORCHID PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

FEATURED VIDEOS

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

Rakesh Jhunjhunwala's Rs 500 Crore Bet on Tata Motors: A Sixer or a Hit-Wicket?

More Featured Videos

MARKET STATS